Alnylam Pharmaceuticals Inc Q1 2021 Earnings Call Summary - Thomson StreetEvents

Alnylam Pharmaceuticals Inc Q1 2021 Earnings Call Summary

Alnylam Pharmaceuticals Inc Q1 2021 Earnings Call Summary - Thomson StreetEvents
Alnylam Pharmaceuticals Inc Q1 2021 Earnings Call Summary
Published Apr 29, 2021
21 pages (11194 words) — Published Apr 29, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of ALNY.OQ earnings conference call or presentation 29-Apr-21 12:30pm GMT

  
Brief Excerpt:

...A. Highlights: 2021 is off to a great start for ALNY with four approved RNAi therapeutics now helping patients around the world and more in Co.'s pipeline poised to do the same in the coming years. 1. 2. Teams delivered steady, ongoing commercial execution and continued revenue growth including 13% quarterly growth for ONPATTRO with Co.'s first triple-digit revenue qtr., and an impressive initial uptake for OXLUMO in its first full qtr., on the market. 3. On the pipeline side, full positive results from the HELIOS-A Phase 3 study of vutrisiran were presented last week and Co. announced it has filed an NDA for vutrisiran with the FDA bringing it a step closer to the potential approval of this important asset in TTR franchise. 4. Announced today that Co. expects the HELIOS-B study of vutrisiran in ATTR patients with cardiomyopathy to complete enrollment later this year, earlier than previously anticipated. 5. Regarding broader corporate strategy, Co. announced in Jan., a new set of five year...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Alnylam Pharmaceuticals Inc
Ticker
ALNY.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) Transcript – 2021-06-01 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 1-Jun-21 6:30pm GMT

Alnylam Pharmaceuticals Inc at UBS Global Healthcare Virtual Conference Transcript – 2021-05-25 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 25-May-21 7:00pm GMT

Alnylam Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2021-05-18 – US$ 54.00 – Edited Transcript of ALNY.OQ shareholder or annual meeting 18-May-21 2:30pm GMT

Alnylam Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript – 2021-05-11 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 11-May-21 6:45pm GMT

Alnylam Pharmaceuticals Inc Q1 2021 Earnings Call Transcript – 2021-04-29 – US$ 54.00 – Edited Transcript of ALNY.OQ earnings conference call or presentation 29-Apr-21 12:30pm GMT

Alnylam Pharmaceuticals Inc to Discuss Full 9-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran - Corporate Call Summary – 2021-04-19 – US$ 54.00 – Edited Brief of ALNY.OQ conference call or presentation 19-Apr-21 8:00pm GMT

Alnylam Pharmaceuticals Inc to Discuss Full 9-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran - Corporate Call Transcript – 2021-04-19 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 19-Apr-21 8:00pm GMT

Alnylam Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript – 2021-04-13 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 13-Apr-21 5:30pm GMT

Alnylam Pharmaceuticals Inc at Stifel CNS Day Transcript – 2021-04-01 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 1-Apr-21 3:00pm GMT

Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript – 2021-03-10 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 10-Mar-21 6:15pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Alnylam Pharmaceuticals Inc Q1 2021 Earnings Call Summary" Apr 29, 2021. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2021-Alnylam-Pharmaceuticals-Inc-Earnings-Call-B14662270>
  
APA:
Thomson StreetEvents. (2021). Alnylam Pharmaceuticals Inc Q1 2021 Earnings Call Summary Apr 29, 2021. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2021-Alnylam-Pharmaceuticals-Inc-Earnings-Call-B14662270>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.